These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3191663)

  • 1. Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise.
    Gullestad L; Dolva LO; Søyland E; Kjekshus J
    Clin Physiol; 1988 Oct; 8(5):487-99. PubMed ID: 3191663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise.
    Gullestad L; Dolva LO; Kjeldsen SE; Eide I; Kjekshus J
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):63-71. PubMed ID: 2577280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of potassium and lactate for maximal exercise performance during beta blockade.
    Gullestad L; Dolva LO; Nordby G; Skaaraas K; Larsen S; Kjekshus J
    Scand J Clin Lab Invest; 1989 Oct; 49(6):521-8. PubMed ID: 2574496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.
    Kullmer T; Kindermann W; Singer M
    Eur J Appl Physiol Occup Physiol; 1987; 56(3):292-8. PubMed ID: 2883003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical performance and muscle metabolism during beta-adrenergic blockade in man.
    Kaiser P
    Acta Physiol Scand Suppl; 1984; 536():1-53. PubMed ID: 6151777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.
    Vyssoulis GP; Kouremetis MT; Valiouli MA; Michaelides AP; Toutouzas PK
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):133-9. PubMed ID: 7786833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blockade and exercise. An update.
    Van Baak MA
    Sports Med; 1988 Apr; 5(4):209-25. PubMed ID: 2897710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.
    Rønnevik PK; Nordrehaug JE; von der Lippe G
    Eur J Clin Pharmacol; 1995; 48(2):127-31. PubMed ID: 7589026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of timolol and metoprolol on platelet function at rest and during exercise.
    Winther K; Knudsen JB; Jørgensen EO; Eldrup E
    Eur J Clin Pharmacol; 1988; 33(6):587-92. PubMed ID: 2896594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of physical endurance and metabolism during acute beta 1 and beta 1/2-blockade].
    Kindermann W; Scheerer W; Salas-Fraire O; Biro G; Wölfing A
    Z Kardiol; 1984 Jun; 73(6):380-7. PubMed ID: 6147940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of ophthalmic timolol.
    Leier CV; Baker ND; Weber PA
    Ann Intern Med; 1986 Feb; 104(2):197-9. PubMed ID: 3946944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of naloxone and timolol on maximal exercise capacity and the subjective perception of fatigue.
    Gullestad L; Dolva LO; Aase O; Kjekshus J
    Int J Sports Med; 1989 Aug; 10(4):259-63. PubMed ID: 2606592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, exercise, and beta-adrenergic blockade.
    Ades PA; Gunther PG; Meacham CP; Handy MA; LeWinter MM
    Ann Intern Med; 1988 Oct; 109(8):629-34. PubMed ID: 2901818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
    Folgering HT; Borm JF; van Haaren RH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and chronic metoprolol administration during submaximal and maximal exercise.
    van Baak MA; Jennen W; Muijtjens A; Verstappen FT
    Int J Sports Med; 1985 Dec; 6(6):347-52. PubMed ID: 4077364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of beta-blockade on plasma potassium concentrations and muscle excitability following static exercise.
    Unsworth K; Hicks A; McKelvie R
    Pflugers Arch; 1998 Aug; 436(3):449-56. PubMed ID: 9644229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism.
    Kaiser P; Tesch PA; Frisk-Holmberg M; Juhlin-Dannfelt A; Kaijser L
    Clin Physiol; 1986 Apr; 6(2):197-207. PubMed ID: 3006981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.